Drugs targeting the glucagon-like peptide 1 receptor (GLP-1R) offer several positive effects for individuals with type 2 ...
A new study suggests GLP-1 weight-loss drugs – such as Ozempic – might affect medical imagining scans and interfere with doctors’ ability to detect diseases.
GLP-1 drugs such as Ozempic are accelerating interest in protein to address the loss of lean muscle mass that can accompany ...
Beyond type 2 diabetes and weight loss, GLP-1 agonists can also help lower blood pressure, improve lipid disorders, reduce ...
Evolv has launched a supplement featuring yeast engineered to produce a peptide that engages GLP-1 receptors, with a ...
The jabs side effects have been widely discussed, ranging from nausea to even organ damage. Now, doctors have warned it may ...
Pfizer acquired a smaller company for $4.9 billion to improve its prospects in the GLP-1 market. The pharmaceutical giant could carve out a small niche for itself in this growing space. Pfizer's ...
More and more people are considering using GLP-1 drugs for weight loss. But there are concerns about products being advertised as so-called "GLP-1 patches." Stream Connecticut News for free, 24/7, ...
Glucagon-like peptide-1 receptor agonists (GLP-1RAs) currently available for the treatment of obesity are administered as a peptide-based subcutaneous injection, but oral (non-peptide) versions would ...
While popular obesity and type 2 diabetes medications, such as Ozempic and Wegovy, have continued to grow in demand and usage across the U.S., there may be a new type on the horizon. Ozempic and ...
Of all the possible side effects that come with taking a GLP-1, losing your hair is perhaps one of the scariest. The good news is this hair loss is typically temporary and will resolve over time. To ...
For years, the pancreas has been being taught in biology class as an easy system: insulin lowers blood sugar, and glucagon raises it. But that’s much too simple, new research says. Scientists at Duke ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results